| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CNTLN mRNA" | 22698814 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CNTLN mRNA" | 25510870 |
| C081766 | 2,4,4'-trichlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CNTLN mRNA" | 25510870 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CNTLN mRNA" | 25510870 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CNTLN mRNA" | 25510870 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CNTLN mRNA" | 25510870 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTLN mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CNTLN mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CNTLN mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTLN mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CNTLN mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CNTLN mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of CNTLN mRNA | 29067470 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of CNTLN mRNA | 17562736 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CNTLN mRNA | 22316170 |
| C006780 | bisphenol A | bisphenol A affects the expression of CNTLN mRNA | 22574217 |
| C006780 | bisphenol A | bisphenol A affects the expression of CNTLN mRNA | 25181051 |
| C018475 | butyraldehyde | butyraldehyde results in decreased expression of CNTLN mRNA | 26079696 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of CNTLN mRNA | 24982889 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CNTLN gene | 20938992 |
| D003703 | Demecolcine | Demecolcine results in decreased expression of CNTLN mRNA | 23649840 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of CNTLN mRNA | 21266533 |
| D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in decreased expression of CNTLN mRNA | 27392435 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of CNTLN mRNA | 27392435 |
| C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CNTLN mRNA | 22079256 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CNTLN gene | 20938992 |
| C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in decreased expression of CNTLN mRNA | 27392435 |
| C544151 | jinfukang | jinfukang results in decreased expression of CNTLN mRNA | 27392435 |
| C045463 | leflunomide | leflunomide results in increased expression of CNTLN mRNA | 28988120 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CNTLN gene | 20938992 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of CNTLN mRNA | 28001369 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of CNTLN mRNA | 26011545 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of CNTLN mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of CNTLN mRNA" | 25554681 |
| C410127 | PCB 180 | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CNTLN mRNA" | 25510870 |
| C046012 | pentanal | pentanal results in decreased expression of CNTLN mRNA | 26079696 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTLN mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in decreased expression of CNTLN mRNA | 26272509 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of CNTLN mRNA | 23557933 |
| D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls affects the expression of CNTLN mRNA | 21334430 |
| C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CNTLN mRNA | 22079256 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of CNTLN mRNA | 22079256 |
| D011374 | Progesterone | Progesterone results in increased expression of CNTLN mRNA | 19690047 |
| D012293 | Rifampin | Rifampin results in increased expression of CNTLN mRNA | 24552687 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CNTLN mRNA | 22574217 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CNTLN mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of CNTLN mRNA | 24935251|2627250 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CNTLN mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of CNTLN mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of CNTLN mRNA | 27188386|2800136 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of CNTLN mRNA | 26272509 |
| D001335 | Vehicle Emissions | Vehicle Emissions affects the methylation of CNTLN gene | 25560391 |
| D014750 | Vincristine | Vincristine results in decreased expression of CNTLN mRNA | 23649840 |